Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808047780> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2808047780 abstract "Background Denosumab 60 mg subcutaneously Q6M increased spine and hip BMD significantly more than risedronate 5 mg orally QD at 12 months in glucocorticoid-treated subjects (as previously reported¹). Objectives This analysis compared the BMD effects of denosumab vs risedronate and further characterised denosumab safety in this population at 24 months. Methods This phase 3, randomised, double-blind, double-dummy study enrolled adults≥18 years receiving ≥7.5 mg daily prednisone (or equivalent) for Results Of 795 randomised subjects, 590 (74.2%) completed the 24 month study (glucocorticoid-initiating: 109/145 denosumab, 117/145 risedronate; glucocorticoid-continuing: 186/253 denosumab, 178/252 risedronate). Denosumab was superior to risedronate for increases from baseline in LS and TH BMD at all timepoints assessed through 24 months in each subpopulation (figure 1). Adverse events, serious adverse events (including infection), and fractures were similar between groups. Conclusions In conclusion, denosumab was superior to risedronate for increases in spine and hip BMD through 24 months. The overall safety profile was similar between groups. Denosumab may offer a valuable osteoporosis treatment option for patients receiving glucocorticoids. Reference [1] Saag K, Wagman RB, Geusens P, et al. Effect of denosumab compared with risedronate in glucocorticoid-treated individuals: Results from the 12-month primary analysis of a randomized, double-blind, active-controlled study. Ann Rheum Dis2017:76(Suppl 2):54. Acknowledgements This study was funded by Amgen Inc. Jonathan Latham (PharmaScribe, LLC) and Lisa Humphries (Amgen Inc.) provided medical writing support. Disclosure of Interest K. Saag Grant/research support from: Amgen, Merck, Consultant for: Amgen, Lilly, Merck, Radius, N. Pannacciulli Shareholder of: Amgen, Employee of: Amgen, P. Geusens Grant/research support from: Abbott, Amgen, BMS, Celgene, Janssen, Lilly, MSD, Novartis, Pfizer, Roche, UCB, Will-Pharma, Consultant for: Amgen, Lilly, J. Adachi Grant/research support from: Amgen, Consultant for: Amgen, Employee of: McMaster University, Speakers bureau: Amgen, O. Messina: None declared, J. Morales-Torres Consultant for: Amgen, Speakers bureau: Amgen, R. Emkey Speakers bureau: Amgen, P. Butler Shareholder of: Amgen, Employee of: Amgen, X. Yin Shareholder of: Amgen, Employee of: Amgen, W. Lems Consultant for: Amgen, Eli Lilly, Merck, Speakers bureau: Amgen, Eli Lilly, Merck" @default.
- W2808047780 created "2018-06-21" @default.
- W2808047780 creator A5013793995 @default.
- W2808047780 creator A5015862721 @default.
- W2808047780 creator A5037172649 @default.
- W2808047780 creator A5046382845 @default.
- W2808047780 creator A5054434839 @default.
- W2808047780 creator A5055923554 @default.
- W2808047780 creator A5062747501 @default.
- W2808047780 creator A5073822694 @default.
- W2808047780 creator A5075601927 @default.
- W2808047780 creator A5075695885 @default.
- W2808047780 date "2018-06-01" @default.
- W2808047780 modified "2023-09-26" @default.
- W2808047780 title "OP0345 Denosumab compared with risedronate in glucocorticoid-treated subjects: results from the final 24-month analysis of a randomised, double-blind, double-dummy study" @default.
- W2808047780 doi "https://doi.org/10.1136/annrheumdis-2018-eular.1406" @default.
- W2808047780 hasPublicationYear "2018" @default.
- W2808047780 type Work @default.
- W2808047780 sameAs 2808047780 @default.
- W2808047780 citedByCount "0" @default.
- W2808047780 crossrefType "proceedings-article" @default.
- W2808047780 hasAuthorship W2808047780A5013793995 @default.
- W2808047780 hasAuthorship W2808047780A5015862721 @default.
- W2808047780 hasAuthorship W2808047780A5037172649 @default.
- W2808047780 hasAuthorship W2808047780A5046382845 @default.
- W2808047780 hasAuthorship W2808047780A5054434839 @default.
- W2808047780 hasAuthorship W2808047780A5055923554 @default.
- W2808047780 hasAuthorship W2808047780A5062747501 @default.
- W2808047780 hasAuthorship W2808047780A5073822694 @default.
- W2808047780 hasAuthorship W2808047780A5075601927 @default.
- W2808047780 hasAuthorship W2808047780A5075695885 @default.
- W2808047780 hasBestOaLocation W28080477801 @default.
- W2808047780 hasConcept C126322002 @default.
- W2808047780 hasConcept C168563851 @default.
- W2808047780 hasConcept C197934379 @default.
- W2808047780 hasConcept C2776286101 @default.
- W2808047780 hasConcept C2776541429 @default.
- W2808047780 hasConcept C2778720950 @default.
- W2808047780 hasConcept C2780841215 @default.
- W2808047780 hasConcept C2908647359 @default.
- W2808047780 hasConcept C71924100 @default.
- W2808047780 hasConcept C99454951 @default.
- W2808047780 hasConceptScore W2808047780C126322002 @default.
- W2808047780 hasConceptScore W2808047780C168563851 @default.
- W2808047780 hasConceptScore W2808047780C197934379 @default.
- W2808047780 hasConceptScore W2808047780C2776286101 @default.
- W2808047780 hasConceptScore W2808047780C2776541429 @default.
- W2808047780 hasConceptScore W2808047780C2778720950 @default.
- W2808047780 hasConceptScore W2808047780C2780841215 @default.
- W2808047780 hasConceptScore W2808047780C2908647359 @default.
- W2808047780 hasConceptScore W2808047780C71924100 @default.
- W2808047780 hasConceptScore W2808047780C99454951 @default.
- W2808047780 hasLocation W28080477801 @default.
- W2808047780 hasOpenAccess W2808047780 @default.
- W2808047780 hasPrimaryLocation W28080477801 @default.
- W2808047780 hasRelatedWork W1981165939 @default.
- W2808047780 hasRelatedWork W2124757739 @default.
- W2808047780 hasRelatedWork W2279827378 @default.
- W2808047780 hasRelatedWork W2319342693 @default.
- W2808047780 hasRelatedWork W2326909997 @default.
- W2808047780 hasRelatedWork W2330588325 @default.
- W2808047780 hasRelatedWork W2330823234 @default.
- W2808047780 hasRelatedWork W2332346805 @default.
- W2808047780 hasRelatedWork W2407731553 @default.
- W2808047780 hasRelatedWork W2551965739 @default.
- W2808047780 hasRelatedWork W2553126827 @default.
- W2808047780 hasRelatedWork W2734413734 @default.
- W2808047780 hasRelatedWork W2754089339 @default.
- W2808047780 hasRelatedWork W2754690624 @default.
- W2808047780 hasRelatedWork W2776889447 @default.
- W2808047780 hasRelatedWork W2949353329 @default.
- W2808047780 hasRelatedWork W2949993699 @default.
- W2808047780 hasRelatedWork W2952617971 @default.
- W2808047780 hasRelatedWork W3034735588 @default.
- W2808047780 hasRelatedWork W3043705891 @default.
- W2808047780 isParatext "false" @default.
- W2808047780 isRetracted "false" @default.
- W2808047780 magId "2808047780" @default.
- W2808047780 workType "article" @default.